Emphascience, Inc.

Innovations for Better Medicines

Redesigning existing medicines to uncover new possibilities.

Who We Are

Emphascience, Inc. is a private pharmaceutical company, focused on developing novel formulations of proven drug products to address unmet medical needs in the treatment of pain, cancer, infections, and many fatal and debilitating diseases.

Learn More About Emphascience, Inc.
Highlights

Reformulated Products

1 of 7

Why reformulate? Pharmaceutical R&D productivity is stifled by the staggering cost (ca. $1 billion), damaging odds of success (<10% in the clinic), and time (>13 years) to develop one new molecular entity. Optimized formulations of approved drugs being developed by Emphascience, on the other hand, can offer new therapeutic applications, market exclusivity and brand differentiation in as little as 30 months and at an insignificant fraction of the cost.